The ACT-Accelerator is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

It was launched in April 2020, at an event co-hosted by the Director-General of the World Health Organization, the President of France, the President of the European Commission, and the Bill & Melinda Gates Foundation.

From research to rollout, the ACT-Accelerator remains the world’s only end-to-end solution to end the COVID-19 pandemic.

The partnership comprises the three pillars of Diagnostics, Therapeutics and Vaccines (COVAX), with a cross-cutting Health Systems and Response Connector (HSRC) and Access and Allocation workstream. The co-convening agencies of the ACT-Accelerator are: CEPI, FIND, Gavi, The Global Fund, UNICEF, Unitaid, Wellcome, WHO, the World Bank and The Bill & Melinda Gates Foundation. The agencies work closely with governments, scientists, businesses, civil society, and philanthropists.

• The Vaccines  Pillar, COVAX, supports countries’ needs and own goals to control the disease and reopen society in 2022 and beyond, contributing towards the 70% global vaccination target in 2022. COVAX is convened by CEPI, Gavi and WHO. UNICEF is global delivery partner, with PAHO covering the Americas.
• The Therapeutics Pillar supports access to safe and effective therapeutics of assured quality to save millions of lives from COVID-19 and to minimise its global health and economic threat. The therapeutics pillar is co-led by Unitaid, the Global Fund and Wellcome.
• The Diagnostics Pillar has an overall objective to significantly increase access to COVID-19 tests and sequencing, which will ensure effective test, trace, isolate, and treat strategies, as well as early identification and containment of new variants. The pillar is co-convened by the Global Fund and FIND.
• The Health Systems & Response Connector (HSRC) ensures all countries have the necessary technical, operational and financial resources to translate new COVID-19 tools into national response interventions to stop transmission and save lives. HSRC is co-convened by the Global Fund, World Bank and WHO, with UNICEF.